Found: 35
Select item for more details and to access through your institution.
Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Ethical Implications of Rejecting Patients for Clinical Trials.
- Published in:
- 1990
- By:
- Publication type:
- Letter
A single-dose study of denosumab in patients with various degrees of renal impairment.
- Published in:
- Journal of Bone & Mineral Research, 2012, v. 27, n. 7, p. 1471, doi. 10.1002/jbmr.1613
- By:
- Publication type:
- Article
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis.
- Published in:
- Journal of Bone & Mineral Research, 2012, v. 27, n. 1, p. 211, doi. 10.1002/jbmr.536
- By:
- Publication type:
- Article
Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 2, p. 242, doi. 10.1002/jbmr.212
- By:
- Publication type:
- Article
Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 5, p. 937, doi. 10.1359/jbmr.091035
- By:
- Publication type:
- Article
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 1, p. 72, doi. 10.1359/jbmr.090716
- By:
- Publication type:
- Article
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 1, p. 153, doi. 10.1359/jbmr.0809010
- By:
- Publication type:
- Article
Nonmalignant Complications of Paget's Disease.
- Published in:
- Journal of Bone & Mineral Research, 2006, v. 21, p. P64, doi. 10.1359/JBMR.06S212
- By:
- Publication type:
- Article
Are We Treating Women With Postmenopausal Osteoporosis for Their Low BMD or High Fracture Risk?
- Published in:
- Journal of Bone & Mineral Research, 2005, v. 20, n. 11, p. 2064, doi. 10.1359/JBMR.050912
- By:
- Publication type:
- Article
Identification of a Novel Tandem Duplication in Exon 1 of the TNFRSF11A Gene in Two Unrelated Patients With Familial Expansile Osteolysis.
- Published in:
- Journal of Bone & Mineral Research, 2003, v. 18, n. 2, p. 376, doi. 10.1359/jbmr.2003.18.2.376
- By:
- Publication type:
- Article
Hearing loss as a complication of paget's disease of bone.
- Published in:
- Journal of Bone & Mineral Research, 1999, v. 14, n. S2, p. 92, doi. 10.1002/jbmr.5650140219
- By:
- Publication type:
- Article
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The Effects of Ronacaleret, a Calcium-Sensing Receptor Antagonist, on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Women with Low Bone Mineral Density.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 8, p. 2441, doi. 10.1210/jc.2010-2855
- By:
- Publication type:
- Article
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 4, p. 972, doi. 10.1210/jc.2010-1502
- By:
- Publication type:
- Article
A Rat Model for Hormone and Mineral Changes in Chronic Renal Failure<sup>1</sup>.
- Published in:
- Proceedings of the Society for Experimental Biology & Medicine, 1983, v. 174, n. 2, p. 193, doi. 10.3181/00379727-174-41724
- By:
- Publication type:
- Article
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 6, p. 2149, doi. 10.1210/jc.2007-2814
- By:
- Publication type:
- Article
Effects of Atorvastatin on Bone in Postmenopausal Women with Dyslipidemia: A Double-Blind, Placebo-Controlled, Dose-Ranging Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 12, p. 4671, doi. 10.1210/jc.2006-1909
- By:
- Publication type:
- Article
Pins and Plaster Aren’t Enough: A Call for the Evaluation and Treatment of Patients with Osteoporotic Fractures.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 8, p. 3482, doi. 10.1210/jc.2003-030568
- By:
- Publication type:
- Article
Alendronate Increases Bone Mass and Reduces Bone Markers in Postmenopausal African-American Women.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 6, p. 2792, doi. 10.1210/jcem.87.6.8575
- By:
- Publication type:
- Article
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 9, p. 3109, doi. 10.1210/jcem.85.9.6777
- By:
- Publication type:
- Article
Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women*.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 1, p. 265, doi. 10.1210/jcem.82.1.3682
- By:
- Publication type:
- Article
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
- Published in:
- Journal of the Endocrine Society, 2023, v. 7, n. 5, p. 1, doi. 10.1210/jendso/bvad043
- By:
- Publication type:
- Article
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Significant Differential Effects of Alendronate, Estrogen, or Combination Therapy on the Rate of Bone Loss after Discontinuation of Treatment of Postmenopausal Osteoporosis.
- Published in:
- Annals of Internal Medicine, 2002, v. 137, n. 11, p. 875, doi. 10.7326/0003-4819-137-11-200212030-00008
- By:
- Publication type:
- Article
Vitamin D and Cardiovascular Disease.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 6, p. 691, doi. 10.1592/phco.29.6.691
- By:
- Publication type:
- Article
Hypercalcemia associated with Wegener's granulomatosis and hyperparathyroidism: etiology and management.
- Published in:
- 1993
- By:
- Publication type:
- journal article
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis.
- Published in:
- Annals of Internal Medicine, 2007, v. 146, n. 5, p. 326
- By:
- Publication type:
- Article
Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double‐Blind, Phase 2, Parallel Group Study.
- Published in:
- Journal of Bone & Mineral Research, 2018, v. 33, n. 8, p. 1397, doi. 10.1002/jbmr.3452
- By:
- Publication type:
- Article
Safety Observations With 3 Years of Denosumab Exposure: Comparison Between Subjects Who Received Denosumab During the Randomized FREEDOM Trial and Subjects Who Crossed Over to Denosumab During the FREEDOM Extension.
- Published in:
- Journal of Bone & Mineral Research, 2017, v. 32, n. 7, p. 1481, doi. 10.1002/jbmr.3119
- By:
- Publication type:
- Article